End-of-Dose Effect as a Guide for Biologic Optimization in Hidradenitis Suppurativa.
Importance Up to one-half of patients treated with licensed biologics for hidradenitis suppurativa (HS) achieve only a partial response, yet no consensus exists on subsequent management. Dose intensification and long-term antibiotic addition are used in routine practice, but real-world data on their effectiveness remai...